Gritstone bio Investor Relations Material

Gritstone bio Inc. is a biotechnology company that develops immunotherapies aimed at treating cancer and infectious diseases. The company leverages its expertise in genomics, machine learning, and immune system biology to create therapeutic vaccines and antibody-based treatments. Gritstone bio focuses on advancing precision medicine through innovative platforms designed to stimulate the immune system to recognize and combat specific disease targets. The company is headquartered in Emeryville, California, and its shares are listed on the NASDAQ.